At the time of writing, Citius Pharmaceuticals Inc [CTXR] stock is trading at $1.44, up 2.86%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CTXR shares have gain 45.45% over the last week, with a monthly amount drifted -4.64%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Citius Pharmaceuticals Inc [NASDAQ: CTXR] stock has seen the most recent analyst activity on December 30, 2024, when D. Boral Capital upgraded its rating to a Buy but kept the price target unchanged to $9 for it. Previously, Maxim Group started tracking the stock with Buy rating on November 30, 2021, and set its price target to $4.
For the past year, the stock price of Citius Pharmaceuticals Inc fluctuated between $0.65 and $5.95. Citius Pharmaceuticals Inc [NASDAQ: CTXR] shares were valued at $1.44 at the most recent close of the market.
Analyzing the CTXR fundamentals
Gross Profit Margin for this corporation currently stands at -1.32% with Operating Profit Margin at -263.84%, Pretax Profit Margin comes in at -263.82%, and Net Profit Margin reading is -258.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.62 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3734 points at the first support level, and at 1.3068 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4933, and for the 2nd resistance point, it is at 1.5466.
Ratios To Look Out For
It is important to note that Citius Pharmaceuticals Inc [NASDAQ:CTXR] has a current ratio of 0.47. Also, the Quick Ratio is 0.14, while the Cash Ratio stands at 0.12.
